Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Epiduo and Adherence of Patients Between 12 to 20 Years Using This Drug First Time in the Monotherapy of Moderate Inflammatory Acne

NCT01220102 is registered in ClinicalTrials.gov with Galderma Laboratorium GmbH as lead sponsor.

NCT NCT01220102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01220102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Epiduo and Adherence of Patients Between 12 to 20 Years Using This Drug First Time in the Monotherapy of Moderate Inflammatory Acne
Lead sponsor
Galderma Laboratorium GmbH
Phase
Observational
Overall status
Completed
Start date
May 31, 2010
Completion date
November 30, 2010
Enrollment
3,113 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acne